Medical cannabis in residential transition or addiction programs a review of clinical and cost-effectiveness and guidelines
The purpose of this Rapid Response is to review the clinical effectiveness, the cost-effectiveness, and the evidence-based guidelines regarding the use of medical cannabis to treat adults with addiction in residential transition/addiction programs
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, April 5, 2017
|
Series: | Rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this Rapid Response is to review the clinical effectiveness, the cost-effectiveness, and the evidence-based guidelines regarding the use of medical cannabis to treat adults with addiction in residential transition/addiction programs |
---|---|
Physical Description: | 1 PDF file (8 pages) illustrations |